Skip to content

Expanded Access to RGX-202

Status
TEMPORARILY_NOT_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT07652606
Enrollment
Unknown
Registered
2026-06-17
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Provide single patient expanded access to RGX-202 for eligible patients

Interventions

GENETICRGX-202

Sponsors

REGENXBIO Inc.
Lead SponsorINDUSTRY

Eligibility

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 18, 2026